Further Reading

Tuesday, 14 January 2025

Scientists sound alarm about using mosquitoes to vaccinate humans

Human clinical trials are underway to use mosquitoes to vaccinate people against malaria, cardiologist Dr. Peter McCullough reported on his Substack.

McCullough cited a paper published in the New England Journal of Medicine (NEJM) in November reporting results from a double-blind, controlled clinical trial at two university medical centers in the Netherlands.

The trial evaluated the safety, side effects and efficacy of immunizing people via mosquito bites, using mosquitoes infected with a genetically engineered version of the parasite that causes malaria.

"It seems as if the world of vaccinology has ramped up to a feverish pitch with amplified research, massive funding, and no limit to the extent in which vaccines could be injected into humans," McCullough wrote.

Researchers have been trying to develop a malaria vaccine since the 1960s, but they have been largely unsuccessful. It wasn't until October 2021 that the World Health Organization (WHO) recommended the first malaria vaccine, made by GSK, for children living in sub-Saharan Africa and other high-transmission regions.

Two years later, the WHO recommended a second malaria vaccine, developed by Oxford University and manufactured by the Serum Institute of India.

The vaccines, given to small children in four doses, offer only modest and short-lived protection — 50-80% efficacy for less than a year — and are even less effective in infants in high endemic areas.

Malaria is caused by plasmodium parasites, which spread to humans through bites from infected mosquitoes.

Given the limited efficacy of existing vaccines, researchers continue researching alternative vaccination strategies, including using genetically modified versions of the malaria parasites to elicit an immune response.

"In a simplified view, the innovation may seem like a good idea," Karl Jablonowski, Ph.D., senior research scientist at Children's Health Defense, told The Defender. "Malaria commonly afflicts those in poorer countries with limited access to healthcare. If we could make a change to the environment that improves the lives of all and diminishes the lives of none, in theory that would be progress."

"The problem," he said, "is that every detail of it looks like a bad idea."...<<<Read More>>>...